Releasing the power of collaborations
Emerge Biotech is partnering with the biomedical industry and academic research organizations on a national and international level to advance the quality of antibodies. Our technology can be harnessed to identify specific antibody mimetics or alternative affinity binders, to exclude polyspecificity and to prevent off-target effects. We are seeking collaborations for proof-of-concept studies on antibody mimetics.

Interrogating the specificity of antibodies from large antibody libraries using Emerge Biotech’s high-throughput screening technology* provides an unprecedented method of identifying superior antibodies. This screening process also provides the first platform for the validation of novel immunization technologies.

For more information please contact us at

*patent pending